Cellular HIV-1 restriction factors: a new avenue for AIDS therapy?

ISSN： 1746-0794

Source： Future Virology, Vol.5, Iss.4, 2010-07, pp. : 417-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-1 Integrase: A Target for New AIDS Chemotherapeutics

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. : 979-990

Bentham Science Publishers

Access to resources Recommend Favorite

The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 76-110

Bentham Science Publishers

Access to resources Recommend Favorite

Triple therapy: valuable new era in treating HIV/AIDS

Inpharma, Vol. 1, Iss. 1268, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Triple therapy: valuable new era in treating HIV/AIDS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 293, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Cellular Immunity and DNA Vaccines for the Treatment of HIV / AIDS

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 3, Iss. 1, 2004-03 ,pp. : 31-41

Bentham Science Publishers

Access to resources Recommend Favorite